|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review |
 |
In the
Antiplatelet Trialists' Collaboration analysis, which included 174 studies
with approximately 100,000 patients, patients with diabetes had a
significant reduction in cardiovascular disease, with a reduction in
relative risk similar to that of patients without diabetes. Reference: Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106. |